• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由β-淀粉样蛋白寡聚体诱导的阿尔茨海默病型神经元tau蛋白过度磷酸化

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

作者信息

De Felice Fernanda G, Wu Diana, Lambert Mary P, Fernandez Sara J, Velasco Pauline T, Lacor Pascale N, Bigio Eileen H, Jerecic Jasna, Acton Paul J, Shughrue Paul J, Chen-Dodson Elizabeth, Kinney Gene G, Klein William L

机构信息

Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, Evanston, IL 60208, USA.

出版信息

Neurobiol Aging. 2008 Sep;29(9):1334-47. doi: 10.1016/j.neurobiolaging.2007.02.029. Epub 2007 Apr 2.

DOI:10.1016/j.neurobiolaging.2007.02.029
PMID:17403556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3142933/
Abstract

Alzheimer's disease (AD) is characterized by presence of extracellular fibrillar A beta in amyloid plaques, intraneuronal neurofibrillary tangles consisting of aggregated hyperphosphorylated tau and elevated brain levels of soluble A beta oligomers (ADDLs). A major question is how these disparate facets of AD pathology are mechanistically related. Here we show that, independent of the presence of fibrils, ADDLs stimulate tau phosphorylation in mature cultures of hippocampal neurons and in neuroblastoma cells at epitopes characteristically hyperphosphorylated in AD. A monoclonal antibody that targets ADDLs blocked their attachment to synaptic binding sites and prevented tau hyperphosphorylation. Tau phosphorylation was blocked by the Src family tyrosine kinase inhibitor, 4-amino-5-(4-chlorophenyl)-7(t-butyl)pyrazol(3,4-D)pyramide (PP1), and by the phosphatidylinositol-3-kinase inhibitor LY294002. Significantly, tau hyperphosphorylation was also induced by a soluble aqueous extract containing A beta oligomers from AD brains, but not by an extract from non-AD brains. A beta oligomers have been increasingly implicated as the main neurotoxins in AD, and the current results provide a unifying mechanism in which oligomer activity is directly linked to tau hyperphosphorylation in AD pathology.

摘要

阿尔茨海默病(AD)的特征是在淀粉样斑块中存在细胞外纤维状β淀粉样蛋白(Aβ)、由聚集的高度磷酸化tau蛋白组成的神经元内神经原纤维缠结以及脑内可溶性Aβ寡聚体(ADDLs)水平升高。一个主要问题是AD病理学的这些不同方面在机制上是如何相关的。在此我们表明,与纤维的存在无关,ADDLs在海马神经元成熟培养物和神经母细胞瘤细胞中刺激tau蛋白在AD中特征性高度磷酸化的表位处发生磷酸化。一种靶向ADDLs的单克隆抗体阻断了它们与突触结合位点的附着,并防止了tau蛋白的过度磷酸化。tau蛋白磷酸化被Src家族酪氨酸激酶抑制剂4-氨基-5-(4-氯苯基)-7-(叔丁基)吡唑并[3,4-d]嘧啶(PP1)以及磷脂酰肌醇-3-激酶抑制剂LY294002所阻断。值得注意的是,来自AD脑的含有Aβ寡聚体的可溶性水提取物也能诱导tau蛋白过度磷酸化,但非AD脑提取物则不能。Aβ寡聚体越来越多地被认为是AD中的主要神经毒素,目前的结果提供了一种统一机制,即寡聚体活性在AD病理学中直接与tau蛋白过度磷酸化相关联。

相似文献

1
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.由β-淀粉样蛋白寡聚体诱导的阿尔茨海默病型神经元tau蛋白过度磷酸化
Neurobiol Aging. 2008 Sep;29(9):1334-47. doi: 10.1016/j.neurobiolaging.2007.02.029. Epub 2007 Apr 2.
2
Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases.暴露于β淀粉样肽后神经元蛋白(包括tau蛋白和粘着斑激酶)的快速酪氨酸磷酸化:Src家族蛋白激酶的参与
J Neurosci. 2002 Jan 1;22(1):10-20. doi: 10.1523/JNEUROSCI.22-01-00010.2002.
3
Systematic analysis of time-dependent neural effects of soluble amyloid β oligomers in culture and in vivo: Prevention by scyllo-inositol.可溶性淀粉样β寡聚体在培养物和体内的时间依赖性神经效应的系统分析:肌醇的预防作用
Neurobiol Dis. 2015 Oct;82:152-163. doi: 10.1016/j.nbd.2015.05.020. Epub 2015 Jun 6.
4
Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures.β-淀粉样肽可诱导大鼠原代隔区培养物中tau蛋白磷酸化及胆碱能神经元丢失。
Neuroscience. 2002;115(1):201-11. doi: 10.1016/s0306-4522(02)00404-9.
5
Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.非人灵长类动物中由β-淀粉样蛋白寡聚体诱导的阿尔茨海默病样病理变化。
J Neurosci. 2014 Oct 8;34(41):13629-43. doi: 10.1523/JNEUROSCI.1353-14.2014.
6
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.β-淀粉样寡聚体通过c-Jun氨基末端激酶信号通路诱导tau蛋白磷酸化和胰岛素受体底物失活:ω-3脂肪酸和姜黄素的抑制作用
J Neurosci. 2009 Jul 15;29(28):9078-89. doi: 10.1523/JNEUROSCI.1071-09.2009.
7
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
8
The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.新型钙蛋白酶抑制剂 A-705253 可预防体外和体内应激诱导的 tau 过度磷酸化。
Neuropharmacology. 2012 Sep;63(4):606-12. doi: 10.1016/j.neuropharm.2012.05.011. Epub 2012 May 18.
9
Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.靶向 CCR3 减少阿尔茨海默病小鼠模型中的淀粉样β生成、tau 过度磷酸化和突触丢失。
Mol Neurobiol. 2017 Dec;54(10):7964-7978. doi: 10.1007/s12035-016-0269-5. Epub 2016 Nov 23.
10
Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.通过氨基四氢呋喃衍生物 ANAVEX2-73 阻断 Tau 过度磷酸化和 Aβ₁₋₄₂ 的产生,该化合物是一种混合毒蕈碱和 σ₁ 受体激动剂,在阿尔茨海默病的非转基因小鼠模型中。
Neuropsychopharmacology. 2013 Aug;38(9):1706-23. doi: 10.1038/npp.2013.70. Epub 2013 Mar 14.

引用本文的文献

1
The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player.健康与阿尔茨海默病中的微循环、血脑屏障和神经血管单元:异常周细胞是关键因素。
Pharmacol Rev. 2025 May;77(3):100052. doi: 10.1016/j.pharmr.2025.100052. Epub 2025 Mar 13.
2
Reduced protein solubility - cause or consequence in amyloid disease?蛋白质溶解度降低——是淀粉样疾病的原因还是结果?
QRB Discov. 2025 Feb 17;6:e8. doi: 10.1017/qrd.2024.12. eCollection 2025.
3
Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease.用于检测临床前阿尔茨海默病的视网膜和血液生物标志物的关联及多模态模型
Alzheimers Res Ther. 2025 Jan 10;17(1):19. doi: 10.1186/s13195-024-01668-5.
4
The brain network hub degeneration in Alzheimer's disease.阿尔茨海默病中的脑网络枢纽退化
Biophys Rep. 2024 Aug 31;10(4):213-229. doi: 10.52601/bpr.2024.230025.
5
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States.阿尔茨海默病病理学中的小胶质细胞驱动因素:多种参与状态的演变
Proteins. 2024 Sep 1. doi: 10.1002/prot.26723.
6
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting.生长抑素:将认知与阿尔茨海默病联系起来,以作为治疗靶点。
Pharmacol Rev. 2024 Oct 16;76(6):1291-1325. doi: 10.1124/pharmrev.124.001117.
7
Anti-amyloid Antibody Therapies for Alzheimer's Disease.用于阿尔茨海默病的抗淀粉样蛋白抗体疗法
Nucl Med Mol Imaging. 2024 Jun;58(4):227-236. doi: 10.1007/s13139-024-00848-3. Epub 2024 Feb 20.
8
Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.在阿尔茨海默病模型中,对septins进行药理学调节可恢复钙稳态并具有神经保护作用。
Science. 2024 May 31;384(6699):eadd6260. doi: 10.1126/science.add6260.
9
Performance of SOBA-AD blood test in discriminating Alzheimer's disease patients from cognitively unimpaired controls in two independent cohorts.在两个独立队列中,SOBA-AD 血液检测在区分阿尔茨海默病患者和认知正常对照者方面的性能。
Sci Rep. 2024 Apr 4;14(1):7946. doi: 10.1038/s41598-024-57107-w.
10
The Phytochemical Agathisflavone Modulates miR146a and miR155 in Activated Microglia Involving STAT3 Signaling.植物化学物质贝壳杉黄酮通过STAT3信号通路调节活化小胶质细胞中的miR146a和miR155 。
Int J Mol Sci. 2024 Feb 22;25(5):2547. doi: 10.3390/ijms25052547.

本文引用的文献

1
Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.β淀粉样蛋白寡聚体通过一种N-甲基-D-天冬氨酸受体依赖性机制诱导神经元氧化应激,而阿尔茨海默病药物美金刚可阻断该机制。
J Biol Chem. 2007 Apr 13;282(15):11590-601. doi: 10.1074/jbc.M607483200. Epub 2007 Feb 16.
2
Monoclonal antibodies that target pathological assemblies of Abeta.靶向β淀粉样蛋白病理聚集体的单克隆抗体。
J Neurochem. 2007 Jan;100(1):23-35. doi: 10.1111/j.1471-4159.2006.04157.x. Epub 2006 Nov 20.
3
A specific amyloid-beta protein assembly in the brain impairs memory.大脑中一种特定的β-淀粉样蛋白聚集体会损害记忆。
Nature. 2006 Mar 16;440(7082):352-7. doi: 10.1038/nature04533.
4
PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.前列腺素H2衍生的异前列烷加合物会增加β淀粉样蛋白1-42的神经毒性。
J Neurochem. 2006 Feb;96(4):917-23. doi: 10.1111/j.1471-4159.2005.03586.x. Epub 2006 Jan 12.
5
A dynamic relationship between intracellular and extracellular pools of Abeta.淀粉样β蛋白细胞内池与细胞外池之间的动态关系。
Am J Pathol. 2006 Jan;168(1):184-94. doi: 10.2353/ajpath.2006.050593.
6
Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.脑脊液中异常磷酸化的tau蛋白和β淀粉样蛋白片段与轻度认知障碍(MCI)受试者的认知障碍相关。
Neurobiol Aging. 2006 Feb;27(2):237-44. doi: 10.1016/j.neurobiolaging.2005.01.011. Epub 2005 Apr 7.
7
Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.针对β-淀粉样蛋白的抗体在体内和体外均可减少β-淀粉样蛋白寡聚体、糖原合酶激酶-3β激活及tau蛋白磷酸化。
J Neurosci Res. 2006 Feb 15;83(3):374-84. doi: 10.1002/jnr.20734.
8
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.阿尔茨海默病体内模型中β淀粉样蛋白(Aβ)寡聚化的时间进程。Aβ与tau病理之间的联系。
J Biol Chem. 2006 Jan 20;281(3):1599-604. doi: 10.1074/jbc.M507892200. Epub 2005 Nov 10.
9
Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound.新型抗淀粉样蛋白生成化合物2,4-二硝基苯酚促进神经突生成和神经元分化。
FASEB J. 2005 Oct;19(12):1627-36. doi: 10.1096/fj.05-3812com.
10
Deregulation of the phosphatidylinositol-3 kinase signaling cascade is associated with neurodegeneration in Npc1-/- mouse brain.磷脂酰肌醇-3激酶信号级联的失调与Npc1基因敲除小鼠大脑中的神经退行性变有关。
Am J Pathol. 2005 Oct;167(4):1081-92. doi: 10.1016/S0002-9440(10)61197-2.